SEC-sourced researchBeta
RXRX
RECURSION PHARMACEUTICALS, INC.
Company comparison ↗
Data passport
- CIK
- 0001601830
- Exchange
- Nasdaq
- Business activity
- — · SIC 2836
- Financial inputs
- 6/6
- Filing date
- Oct 7, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 44,575,000.0000 | Feb 25, 2026 |
| December 2024 | 58,839,000.0000 | Feb 25, 2026 |
| December 2025 | 74,681,000.0000 | Feb 25, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 74,681,000.0000 | -644,759,000.0000 | -371,808,000.0000 | 1,474,130,000.0000 | 343,265,000.0000 | Feb 25, 2026 |
| December 2024 | 58,839,000.0000 | -463,661,000.0000 | -359,174,000.0000 | 1,448,598,000.0000 | 413,816,000.0000 | Feb 25, 2026 |
| December 2023 | 44,575,000.0000 | -328,066,000.0000 | -287,780,000.0000 | — | — | Feb 25, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $74.68M | December 2025 | Feb 25, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $58.84M | December 2024 | Feb 25, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$644.76M | December 2025 | Feb 25, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$371.81M | December 2025 | Feb 25, 2026 | 10-K |
| Total assetsAssets | $1.47B | December 2025 | Feb 25, 2026 | 10-K |
| Total liabilitiesLiabilities | $343.27M | December 2025 | Feb 25, 2026 | 10-K |
New filings
- 4RXRX · RECURSION PHARMACEUTICALS, INC.Oct 7, 2026 · Other
- 4RXRX · RECURSION PHARMACEUTICALS, INC.Oct 7, 2026 · Other
- 144RXRX · RECURSION PHARMACEUTICALS, INC.Oct 6, 2026 · Other
- 144RXRX · RECURSION PHARMACEUTICALS, INC.Oct 6, 2026 · Other
- 4RXRX · RECURSION PHARMACEUTICALS, INC.Oct 2, 2026 · Other
- 4RXRX · RECURSION PHARMACEUTICALS, INC.Oct 2, 2026 · Other
- 8-KRXRX · RECURSION PHARMACEUTICALS, INC.Sep 21, 2026 · Current event
- 4RXRX · RECURSION PHARMACEUTICALS, INC.Sep 16, 2026 · Other
- 4RXRX · RECURSION PHARMACEUTICALS, INC.Sep 10, 2026 · Other
- 144RXRX · RECURSION PHARMACEUTICALS, INC.Sep 8, 2026 · Other
- 4RXRX · RECURSION PHARMACEUTICALS, INC.Sep 2, 2026 · Other
- 144RXRX · RECURSION PHARMACEUTICALS, INC.Sep 1, 2026 · Other
- 10-KRXRX · RECURSION PHARMACEUTICALS, INC.Feb 25, 2026 · Annual